Development of acute－on－chronic liver failure in progressive chronic liver diseases： Risk prediction and stratified management
10.3969/j.issn.1001-5256.2023.10.005
- VernacularTitle:进展性慢性肝病发生慢加急性肝衰竭的风险预测及分层管理
- Author:
Tingting QI
1
;
Jinjun CHEN
1
Author Information
1. Liver Disease Center， Nanfang Hospital， Southern Medical University， Guangzhou 510515， China
- Publication Type:Journal Article
- Keywords:
Acute－On－Chronic Liver Failure;
Advanced Chronic Liver Disease;
Models， Statistical;
Biomarkers
- From:
Journal of Clinical Hepatology
2023;39(10):2294-2300
- CountryChina
- Language:Chinese
-
Abstract:
Patients with advanced chronic liver disease （ACLD） are hospitalized due to hepatitis， acute decompensation or liver failure and its complications， and they often require stratified management due to different severities. The patients with acute－on－chronic liver failure （ACLF） have the highest short－term mortality rate among ACLD patients and should be treated in tertiary hospitals. Although non－ACLF patients tend to have a relatively low mortality rate， they still have the risk of progression to ACLF， and there is a significant increase in mortality rate after progression to ACLF， which requires stratified management. The patients with extremely low progression rates often have favorable clinical outcomes and can be administrated in primary hospitals， while the high－risk population should be closely monitored and timely transferred in case of disease progression. However， currently there is still a lack of accurate predictive models for evaluating the risk of progression to ACLF， and further studies are needed to find new biomarkers or algorithms.
